{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:52:34Z","timestamp":1791287554180,"version":"4.1.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/eurheartj\/ehag812","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:45:18Z","timestamp":1790682318000},"source":"Crossref","is-referenced-by-count":0,"title":["Weekly Journal Scan: STAR(EE)ing beyond age: what statins can\u2014and cannot\u2014prevent after 70"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5714-0907","authenticated-orcid":false,"given":"Giovanna","family":"Liuzzo","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli--IRCCS , Largo A. Gemelli 8, Rome 00168 ,","place":["Italy"]},{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University, School of Medicine , Largo F. Vito 1, Rome 00168 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6447-2424","authenticated-orcid":false,"given":"Carlo","family":"Patrono","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University, School of Medicine , Largo F. Vito 1, Rome 00168 ,","place":["Italy"]},{"name":"Center of Excellence on Ageing, CAST, \u2018G. D\u2019Annunzio\u2019 University School of Medicine , Chieti 66013 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"2026100607052148300_ehag812-B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2607314","article-title":"Atorvastatin, cardiovascular events, and disability-free survival in older adults","author":"Zoungas","year":"29, 2026","journal-title":"N Engl J Med"},{"key":"2026100607052148300_ehag812-B2","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"2026100607052148300_ehag812-B3","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","article-title":"Major outcomes in moder-ately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the antihypertensive and lipid-lowering treatment to prevent heart at-tack trial (ALLHAT-LLT)","volume":"288","author":"The ALLHAT Officers and Coordina-tors for the ALLHAT Collaborative Re-search Group","year":"2002","journal-title":"JAMA"},{"key":"2026100607052148300_ehag812-B4","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","article-title":"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the anglo-scandinavian cardiac outcomes trial\u2013lipid lowering arm (ASCOT-LLA): a multi-centre randomised controlled trial","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"2026100607052148300_ehag812-B5","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascu-lar events in men and women with elevat-ed C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"2026100607052148300_ehag812-B6","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N Engl J Med"},{"key":"2026100607052148300_ehag812-B7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","article-title":"Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials","volume":"393","author":"Cholesterol Treatment Trialists\u2019 Collaboration","year":"2019","journal-title":"Lancet"},{"key":"2026100607052148300_ehag812-B8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-069915","article-title":"Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)","volume":"13","author":"Zoungas","year":"2023","journal-title":"BMJ Open"},{"key":"2026100607052148300_ehag812-B9","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","article-title":"Effect of aspirin on disability-free survival in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"2026100607052148300_ehag812-B10","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"2026100607052148300_ehag812-B11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41569-019-0225-y","article-title":"Role of aspirin in primary prevention of cardiovascular disease","volume":"16","author":"Patrono","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"2026100607052148300_ehag812-B12","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1093\/eurheartj\/ehae324","article-title":"Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease","volume":"45","author":"Patrono","year":"2024","journal-title":"Eur Heart J"},{"key":"2026100607052148300_ehag812-B13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(25)01578-8","article-title":"Assessment of ad-verse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials","volume":"407","author":"The Cholesterol Treatment Trialists\u2019 (CTT) Collaboration","year":"2026","journal-title":"Lancet"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag812\/71626053\/ehag812.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article-pdf\/doi\/10.1093\/eurheartj\/ehag812\/71626053\/ehag812.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:05:27Z","timestamp":1791284727000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/advance-article\/doi\/10.1093\/eurheartj\/ehag812\/8868882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":13,"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag812","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"article-number":"ehag812"}}